| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |